POLYPEPTIDE GROUP AG

As of December 31, 2025, POLYPEPTIDE GROUP AG carries a market capitalization of 1.15B, placing it among publicly traded companies globally. Its enterprise value stands at 1.21B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, POLYPEPTIDE GROUP AG has 33.01M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, POLYPEPTIDE GROUP AG maintains a current ratio of 1.74, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of December 31, 2025, POLYPEPTIDE GROUP AG holds 87.64M in cash and equivalents against 153.41M in total debt, resulting in a net debt position of 41.11M. Total book value stands at 400.19M, with working capital of 162.55M providing operational flexibility.